<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02724293</url>
  </required_header>
  <id_info>
    <org_study_id>266</org_study_id>
    <nct_id>NCT02724293</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Peri-operative Pregabalin After Radical Cystectomy</brief_title>
  <official_title>Analgesic Efficacy and Safety of Peri-operative Pregabalin Following Radical Cystectomy, a Prospective,Randomized, Double-blinded, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares analgesic efficacy, and safety of three different doses of peri-operative
      pregabaline to placebo following radical cystectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analogue scale (VAS) score</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>analgesic efficacy of study drugs as represented by the VAS score of the patients in the first 24 hours.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative opioid consumption</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>ability of study drugs to reduce the postoperative opioid analgesic consumption.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>time to first request of opioid analgesia</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>ability of the study drugs to delay the request of rescue opioid analgesia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety assessed by incidence of side effects</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>represented by the incidence of side effects during the follow up period of 24 hours.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Postoperative Pain Following Radical Cystectomy</condition>
  <arm_group>
    <arm_group_label>Group I (placebo)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients received placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (pregabaline 300 once)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients received pregabalin 300 mg 2 hours preoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III (pregabaline 300 twice)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients received pregabalin 300 mg 2 hours preoperatively and 12 hours after the preoperative dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group IV (pregabaline 600)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients received pregabalin 600 mg 2 hours preoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pregabaline 300 mg once.</intervention_name>
    <description>patients received pregabaline 300 mg 2 hours pre-operatively.</description>
    <arm_group_label>Group II (pregabaline 300 once)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pregabaline 300 mg twice.</intervention_name>
    <description>patients received pregabaline 300 mg 2 hours pre-operatively, and 12 hours later.</description>
    <arm_group_label>Group III (pregabaline 300 twice)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pregabaline 600 mg once.</intervention_name>
    <description>patients received pregabaline 600 mg 2 hours pre-operatively.</description>
    <arm_group_label>Group IV (pregabaline 600)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>patients received placebo</description>
    <arm_group_label>Group I (placebo)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sixty patients between the ages of 18 and 60 years.

          -  American Society of Anesthesiologists (ASA) I-II physical status.

          -  undergoing radical cystectomy under general anesthesia.

        Exclusion Criteria:

          -  Patients with a history of drug or alcohol abuse.

          -  patients with chronic pain or daily intake of analgesics.

          -  uncontrolled diabetes mellitus.

          -  uncontrolled hypertension.

          -  atherosclerotic heart disease.

          -  seizures.

          -  impaired kidney or liver functions,

          -  patients with body mass index â‰¥35 kg/m2, and whom

          -  patients that could not control a patient controlled analgesia (PCA) device.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2016</study_first_submitted>
  <study_first_submitted_qc>March 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2016</study_first_posted>
  <last_update_submitted>March 30, 2016</last_update_submitted>
  <last_update_submitted_qc>March 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmad Mohammad Abd El-Rahman</investigator_full_name>
    <investigator_title>Lecturer of anesthesia, icu, and pain management</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

